Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival. Academic Article uri icon

Overview

abstract

  • Of 221 patients with superficial bladder cancers treated with intravesical BCG, BCG therapy failed locally within the bladder or prostate in 41 patients. A multivariate analysis was done using data on these local failures to identify clinical variables influencing survival. Patients presenting with T1 tumors which relapsed initially in the prostate were at highest risk of dying of bladder cancer. Cystectomy is justified in such patients. Others with noninvasive local refractory disease can be managed by continued conservative therapy.

publication date

  • January 1, 1991

Research

keywords

  • BCG Vaccine
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 0026026281

Digital Object Identifier (DOI)

  • 10.1159/000473593

PubMed ID

  • 2022226

Additional Document Info

volume

  • 19

issue

  • 2